关注
Hongxiang Hu
Hongxiang Hu
College of Pharmacy, University of Michigan
在 umich.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Why 90% of clinical drug development fails and how to improve it?
D Sun, W Gao, H Hu, S Zhou
Acta Pharmaceutica Sinica B 12 (7), 3049-3062, 2022
6312022
Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and …
Z Lin, W Gao, H Hu, K Ma, B He, W Dai, X Wang, J Wang, X Zhang, ...
Journal of Controlled Release 174, 161-170, 2014
2062014
Mitigating SOX2-potentiated immune escape of head and neck squamous cell carcinoma with a STING-inducing nanosatellite vaccine
YS Tan, K Sansanaphongpricha, Y Xie, CR Donnelly, X Luo, BR Heath, ...
Clinical Cancer Research 24 (17), 4242-4255, 2018
1312018
Effects of PEGylated paclitaxel nanocrystals on breast cancer and its lung metastasis
H Zhang, H Hu, H Zhang, W Dai, X Wang, X Wang, Q Zhang
Nanoscale 7 (24), 10790-10800, 2015
842015
A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel
H Hu, Z Lin, B He, W Dai, X Wang, J Wang, X Zhang, H Zhang, Q Zhang
Journal of Controlled Release 220, 189-200, 2015
752015
Tumor-derived exosomes: Nanovesicles made by cancer cells to promote cancer metastasis
H Chen, V Chengalvala, H Hu, D Sun
Acta Pharmaceutica Sinica B 11 (8), 2136-2149, 2021
492021
Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation
X Luan, H Yuan, Y Song, H Hu, B Wen, M He, H Zhang, Y Li, F Li, P Shu, ...
Biomaterials 275, 120910, 2021
472021
Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice
Y Song, L Bugada, R Li, H Hu, L Zhang, C Li, H Yuan, KK Rajanayake, ...
Science translational medicine 14 (643), eabl3649, 2022
452022
Transmembrane pathways and mechanisms of rod-like paclitaxel nanocrystals through MDCK polarized monolayer
F Deng, H Zhang, X Wang, Y Zhang, H Hu, S Song, W Dai, B He, Y Zheng, ...
ACS Applied Materials & Interfaces 9 (7), 5803-5816, 2017
402017
Smart nanoparticles undergo phase transition for enhanced cellular uptake and subsequent intracellular drug release in a tumor microenvironment
G Ye, Y Jiang, X Yang, H Hu, B Wang, L Sun, VC Yang, D Sun, W Gao
ACS applied materials & interfaces 10 (1), 278-289, 2018
312018
A comparative investigation between paclitaxel nanoparticle-and nanocrystal-loaded thermosensitive PECT hydrogels for peri-tumoural administration
Z Lin, S Xu, W Gao, H Hu, M Chen, Y Wang, B He, W Dai, H Zhang, ...
Nanoscale 8 (44), 18782-18791, 2016
272016
Self-assembled Au@ Fe core/satellite magnetic nanoparticles for versatile biomolecule functionalization
H Chen, H Hu, C Tao, RM Clauson, I Moncion, X Luan, S Hwang, ...
ACS applied materials & interfaces 11 (27), 23858-23869, 2019
162019
BMS-986393 (CC-95266), a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted chimeric antigen receptor (CAR) T-cell therapy for relapsed/refractory multiple …
S Bal, M Htut, O Nadeem, LD Anderson Jr, H Koçoğlu, T Gregory, ...
Blood 142, 219, 2023
122023
Optimization of the prodrug moiety of Remdesivir to improve lung exposure/selectivity and enhance anti-SARS-CoV-2 activity
H Hu, MD Mady Traore, R Li, H Yuan, M He, B Wen, W Gao, CB Jonsson, ...
Journal of Medicinal Chemistry 65 (18), 12044-12054, 2022
122022
cRGDfK-grafted small-size quercetin micelles for enhancing therapy efficacy of active ingredient from the chinese medicinal herb
P Xu, H Wang, H Hu, Y Ye, Y Dong, S Li, D Mei, Z Guo, D Wang, Y Sun, ...
International Journal of Nanomedicine, 9173-9184, 2019
92019
Structure‒tissue exposure/selectivity relationship (STR) correlates with clinical efficacy/safety
W Gao, H Hu, L Dai, M He, H Yuan, H Zhang, J Liao, B Wen, Y Li, ...
Acta Pharmaceutica Sinica B 12 (5), 2462-2478, 2022
82022
Mechanism and clinical progress of molecular targeted cancer therapy
HX Hu, XQ Wang, H Zhang, Q Zhang
Yao xue xue bao= Acta Pharmaceutica Sinica 50 (10), 1232-1239, 2015
52015
S193: BMS-986393 (CC-95266), AG protein–coupled receptor class C group 5 member D (GPRC5D)–targeted CAR T-cell therapy for relapsed/refractory multiple myeloma (RRMM): results …
S Bal, J Berdeja, M Htut, M Kocoglu, T Gregory, LD Anderson, A Rossi, ...
HemaSphere 7 (S3), e9863287, 2023
32023
Resolving STING-mediated tumor immune microenvironment shift at single-cell resolution
YS Tan, BR Heath, BD Hill, X Luo, SM Rizvi, T Moghbeli, H Hu, E Siismets, ...
CLINICAL CANCER RESEARCH 26 (12), 33-34, 2020
22020
Integrating Full Bayesian Inference and Student's t‐Distribution Method for Enhanced Outlier Handling in Caffeine Population Pharmacokinetics: Assessing Drug–Drug Interactions …
Y Cheng, S Du, H Hu, X Wang, L Carayannopoulos, Y Li
The Journal of Clinical Pharmacology, 2024
12024
系统目前无法执行此操作,请稍后再试。
文章 1–20